-
AbbVie Inc. (ABBV $198.55)
-
Eli Lilly and Company (LLY $765.95)
-
iShares U.S. Medical Devices ETF (IHI $60.47)
Q: My health sector holdings consist of ABBV and IHI, both in a non-registered account. Neither have been stellar performers lately, but both are still up (ABBV by 28%, IHI by 50%). I have my eye on LLY, but the tax consequences of trimming or selling either ABBV or IHI are making me think twice. What would you do in my position? Thank you.